Glimepiride 3 mg & Metformin Hydrochloride 500 mg | SEIZMET G3

Description

SEIZMET G3 is an advanced oral antidiabetic formulation that combines Glimepiride 3 mg and Metformin Hydrochloride 500 mg. This dual-action medicine is commonly prescribed for the effective management of Type 2 Diabetes Mellitus (T2DM), particularly in adults who require stronger glycaemic control than monotherapy can provide. Manufactured with a focus on quality and therapeutic reliability, SEIZMET G3 offers a balanced approach—reducing blood sugar levels while supporting better long-term metabolic outcomes. This combination belongs to two different drug classes: Glimepiride is a sulfonylurea that increases insulin release, while Metformin is a biguanide that improves insulin sensitivity and reduces glucose production in the liver. Together, they deliver comprehensive glycaemic control for diabetic patients. Uses SEIZMET G3 is primarily used for: 1. Management of Type 2 Diabetes Mellitus It helps patients maintain optimal blood glucose levels when diet, exercise, or single-drug therapy alone does not provide adequate control. 2. Reduction of Fasting and Post-Meal Glucose Levels By acting on different pathways of glucose regulation, this combination reduces both fasting and post-prandial blood sugar. 3. Prevention of Diabetes-Related Complications Consistent use helps reduce the risk of complications such as neuropathy, retinopathy, nephropathy, and cardiovascular issues. 4. Improving Insulin Response SEIZMET G3 helps the body utilize insulin more effectively, which is essential in insulin-resistant patients. Benefits 1. Dual Mechanism for Better Control The combination ensures improved glycaemic control by enhancing insulin release and increasing insulin sensitivity simultaneously. 2. Effective for Uncontrolled Diabetes Ideal for patients who do not respond adequately to Glimepiride or Metformin alone. 3. Helps Maintain Long-Term Glycaemic Stability Regular use supports steady HbA1c reduction, helping patients manage long-term sugar fluctuations. 4. Supports Weight Management Metformin is known to help prevent weight gain, making this combination beneficial for overweight diabetic patients. 5. Convenient Once-or-Twice Daily Dosing This improves patient adherence and simplifies diabetes management in everyday life. Dosage The dosage of SEIZMET G3 should be based on individual patient needs and the treating physician’s guidance. Usually taken once or twice daily, preferably with meals to reduce gastric discomfort. Dosage may be adjusted depending on blood sugar levels, response to treatment, and tolerability. Patients should follow a balanced diet, exercise routine, and regular monitoring for best results. Important: Do not self-adjust or skip doses. Take the tablet with water and follow the schedule provided by your doctor. Side Effects SEIZMET G3 is generally well tolerated, but some patients may experience mild to moderate side effects: Common Side Effects Nausea or stomach discomfort Metallic taste Diarrhoea Headache Weakness or tiredness Less Common Side Effects Hypoglycaemia (more likely if meals are skipped) Dizziness Mild skin reactions Rare but Serious Side Effects Lactic acidosis (associated with Metformin; extremely rare) Severe hypoglycaemia Allergic reactions If any of these symptoms persist or worsen, patients should seek medical attention promptly. Precautions and Warning 1. Not for Type 1 Diabetes SEIZMET G3 is strictly for Type 2 Diabetes patients and cannot replace insulin therapy. 2. Avoid Alcohol Alcohol increases the risk of low blood sugar and lactic acidosis. 3. Kidney or Liver Disease Patients with impaired kidney or liver function should use this medicine only if prescribed by a doctor. 4. Pregnancy and Breastfeeding Pregnant or breastfeeding women should consult a healthcare provider before starting this medication. 5. Risk of Hypoglycaemia Skipping meals, excessive exercise, or taking the wrong dose can lead to dangerously low blood sugar. 6. Regular Monitoring Required Patients should check blood sugar levels regularly and undergo periodic kidney and liver function tests. Conclusion SEIZMET G3, containing Glimepiride 3 mg and Metformin Hydrochloride 500 mg, is a reliable and powerful therapy for managing Type 2 Diabetes Mellitus. Its dual-action mechanism delivers comprehensive control over blood sugar levels, making it suitable for adults who require enhanced glycaemic regulation. When combined with proper diet, exercise, and regular medical supervision, SEIZMET G3 helps patients maintain healthier day-to-day glucose levels and reduces the risk of diabetes-related complications.